We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00016406
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : January 24, 2013
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group